Clinical studies recruiting near Englewood

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
Phase N/A · Englewood Hospital · Englewood Hospital and Medical Center · NCT06937996 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Englewood Hospital and Medical Center · NRG Oncology · NCT05624996 Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Phase 2 · Nuclear Imaging Institute · Akiva Mintz · NCT07284589 Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · Swedish Medical Center · University of Cincinnati · NCT05911568 Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury
Phase N/A · Craig Hospital · Craig Hospital · NCT07227740 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Alliance for Clinical Trials in Oncology · NCT07321652 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · South Denver Gastroenterology · Eli Lilly and Company · NCT07483099 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Alliance for Clinical Trials in Oncology · NCT07091617 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Miami Valley Hospital North · PrECOG, LLC. · NCT06538038 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Rocky Mountain Cancer Centers LLP · Pfizer · NCT07144280 Ultralow Dose PET Imaging of 18F-FDG Uptake
Phase 2 · Nuclear Imaging Institute · Akiva Mintz · NCT06956391 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Englewood Hospital and Medical Center · Alliance for Clinical Trials in Oncology · NCT06632327 VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/Phase 2 · Englewood Hospital and Medical Center (site 202) · VM Oncology, LLC · NCT03556228 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Englewood Hospital and Medical Center · Alliance for Clinical Trials in Oncology · NCT06876714 A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Phase 3 · CenExcel Rocky Mtn Clin Research · Novartis Pharmaceuticals · NCT07498426 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · South Denver Gastroenterology, P.C. · Ipsen · NCT06016842 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Mountain Blue Cancer Care Center - Swedish · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Canadian Cancer Trials Group · NCT06592924 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · SWOG Cancer Research Network · NCT05806515 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Englewood Hospital and Medical Center · NRG Oncology · NCT03180268 A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Velocity Clinical Research - Denver · Uniquity One (UNI) · NCT06496620 Endothelial Dysfunction After SCI
Phase N/A · Craig Hospital · Craig Hospital · NCT07227727 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Rocky Mountain Movement Disorders · Hoffmann-La Roche · NCT07174310 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Mountain Blue Cancer Care Center - Swedish · Alliance for Clinical Trials in Oncology · NCT04242095 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Comp
Phase 3 · Research Site · AstraZeneca · NCT07662044 A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P
Phase 2 · Rocky Mountain Clinical Research - CenExel - PPDS (Site #215 · Appello Pharmaceuticals, Inc. · NCT07432958 SELUTION 4 De Novo Small Vessel IDE Trial
NA · Englewood Health · M.A. Med Alliance S.A. · NCT05946629

Look up another city

Look up another condition